Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms

Details for Australian Patent Application No. 2004289221 (hide)

Owner Supernus Pharmaceuticals, Inc

Inventors Kidane, Argaw

Agent Spruson & Ferguson

Pub. Number AU-B-2004289221

PCT Pub. Number WO2005/046655

Priority 60/517,170 04.11.03 US

Filing date 4 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 17 December 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/046655 Priority application(s): WO2005/046655

22 June 2006 Assignment before Grant

  Shire Laboratories Inc. The application has been assigned to Supernus Pharmaceuticals, Inc

17 December 2009 Application Accepted

  Published as AU-B-2004289221

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289222-Compositions of quaternary ammonium containing bioavailability enhancers

2004289219-Wine glass